• Users Online: 343
  • Print this page
  • Email this page
Year : 2022  |  Volume : 26  |  Issue : 2  |  Page : 96-98

Saudi adolescent present with new-onset vitiligo post-COVID-19 vaccination: Case report

1 College of Medicine, King Faisal University, Hofuf, Saudi Arabia
2 Department of Medicine, Section of Dermatology, King Fahad Specialist Hospital, Dammam, Saudi Arabia

Correspondence Address:
Dr. Abdullah A Alnaim
King Faisal University, Hofuf
Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jdds.jdds_35_22

Rights and Permissions

Coronavirus disease of 2019 (COVID-19) is a relatively new pandemic; the first reported case was in late 2019, and the first vaccine was given in December 2020. To this date, multiple side effects have been reported with COVID-19 vaccines. Nonetheless, autoimmune (AI) diseases with the COVID-19 vaccine have rarely been associated. We described herein a case of sudden onset of vitiligo occurring after the first dose of the COVID-19 vaccine. To date, there are less than 10 reported cases of vitiligo post-COVID-19 vaccine. This report aims to recognize AI disease presentation with vaccines, specifically COVID-19.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded51    
    Comments [Add]    

Recommend this journal